Member Info for Inphobe

Hmm, that is not exactly what, you know, specialists in the field are saying PSG. But I guess we've had enough of experts?

Interesting read (realise it's just a guardian article so apologies to the mail readers ;), but spotted as it was linked by a virologist I follow)

https://www.theguardian.com/world/2022/jan/11/will-covid-19-become-less-dangerous-as-it-evolves

Have they hashtagshares? I don't think anyone who listened to them in November would agree, and they were in a frenzy then, one of them was cross ramping a share on here that has dropped significantly since, whereas this has risen. Listen to him or any of the others then and you'd have been properly fkucked.

Back in the real world, away from the misery guts here, seems to me from gdr's communication that they are moving on the commercial launch here. Anyone thinking we will not see partner(s) for the Covid PoC announced fairly shorty will IMO be proven very wrong.

Someone posted below that they cannot see where this will find a market. As that's been gone over before do we need to do it again? It's multiple industries, not necessarily government or just travel (though that).

Meantime the SP will do what it does, very volatile on relatively low vol (good luck traders)

FYI, just up from GDR

https://twitter.com/genedriveplc/status/1480829695528783873?t=sQdVbF2g1NLXWrJDALXUbA&s=19

Today. Those that understand understand.

Onwards, let's see those rns's GDR :)

I can play this game. Looks like the market may be wider open than expected for gdr's Covid LAMP PoC with lft's under question, and with the AIHL also due and seemingly moving toward NICE guidance gdr may at last be right company, right place, right time. 95% of actual shareholders voted for DB to stay.

Tweet (so they HAVE found twitter ;)

https://twitter.com/genedriveplc/status/1480551651891163137?t=0v5Y-d5LQtKjwK7gx4e9KQ&s=19

Be interesting to see what the German study concludes, especially if it includes lft's currently in use here

So many flaws in that post I don't know where to start hashtagshares. But I'll have a go. 1/ it's industry where this is interesting, not necessarily governments. 2/ this is very far from a common cold, as I saw a doctor post the other day 'I never had to intubate someone for a cold'. 3/ EU CE mark was moments ago in the scheme of things, we are only a week into the new year. 4/ UK approval will add another market making it even more attractive to distributors who see the potential for industry. 5/ Most of those you call 'rampers' are just genuine investors, whereas you are genuinely a deramper. 6/ for what it's worth, I anticipate we will have news on distribution deals relatively shortly, but I certainly don't know when. 7/ We will also undoubtedly have news on AIHL, though whether that will be before what appears to be NICE guidance in March I don't know. AIHL alone provides future. 8/ Point of Care in all forms has a great future long term as it is one of the ways diagnostics are moving and why I'm invested (invested, not trading).

More on the lft story, German health minister announced study into effectiveness of rapid tests at weekend

https://www.reuters.com/world/europe/germany-assessing-reliability-antibody-tests-omicron-minister-2022-01-09/

I fully expect industries where speed and accuracy crucial (care, offshore, etc etc) to be adopting LAMP PoC such as gdr's into their mitigation strategies to protect their people and expensive operations

Quite so Expert. Speculation over on avct board is whether other lft's are having issues with Omicron. Never a better time to be in gdr I suspect.

Yeah terrier. Shame about avct and abdx this morning, but any movement here is nowt to do with anything. Though I swear some punters don't know what they invest in. Gdr PoC just gets more interesting.

Great thanks Tricky, nope, rather enjoying it ;) Enjoy the rest of the weekend

Yes tricky, seems the reports have been denied

https://www.theguardian.com/world/2022/jan/09/nadhim-zahawi-denies-there-is-plan-to-end-free-lateral-flow-covid-tests

Drlong, all you've been doing here recently is cross ramping odx, and now trying to make sentiment links between them (a QUITE different company) and GDR. I'll give you a clue, we're up over the last month and a half, they're down, there's your sentiment. And there's a reason for it. At some point you should think about actually posting on THEIR board.

Lloyd, all stocks are affected by sentiment. Is this the best you can do in the continuation of your vendetta here?

Honestly the both of you are so transparent I do not know why you bother. Especially as we are clearly in the pipe for more rns's here, at which point you can hang your sentiment wherever you like ;)

That's because you don't or don't want to understand the use case for point of care going forward next few years Lloyd. And no, he doesn't have "'til end of next week".

Would have thought it may be rocky on sentiment for UK lft companies who were hoping for gov contracts. Luckily we are not one of them ;)

(nor I think is gdr's LAMP PoC primarily aimed at governments, rather industry, or just the UK for that matter)

P.s. nice to see that someone spotted what looks like NICE guidance coming up for (I assume) the AIHL

Was posted on here a couple of days ago, with the same intent. Afaict tiny israeli company. Lower sensitivity/specificity to gdr if it's literature is correct. IMO needs to be higher to meet the use case for care, marine, etc I'd envisage for PoC but that's just my view. Equally wrt regs. Not LAMP afaict, not sure how it'd fit into regs that specify PCR or LAMP. If it is what it says it is, and their website is extremely basic as far as i can see. Imo not a similar player unless shown otherwise but dyor

That tickled some ribs. Wonder why. "Snowflakes" eh.

Back in the real world, seems to me further news getting closer. Again jmo which they don't like.